Your browser doesn't support javascript.
loading
High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms.
Franke, Christiana; Ferse, Caroline; Kreye, Jakob; Reincke, S Momsen; Sanchez-Sendin, Elisa; Rocco, Andrea; Steinbrenner, Mirja; Angermair, Stefan; Treskatsch, Sascha; Zickler, Daniel; Eckardt, Kai-Uwe; Dersch, Rick; Hosp, Jonas; Audebert, Heinrich J; Endres, Matthias; Ploner, J Christoph; Prüß, Harald.
Afiliação
  • Franke C; Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany. Electronic address: christiana.franke@charite.de.
  • Ferse C; Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Germany.
  • Kreye J; Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany; German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany; Department of Pediatric Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Reincke SM; Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany; German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany; Berlin Institute of Health (BIH), Berlin 10178, Germany.
  • Sanchez-Sendin E; German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.
  • Rocco A; Department of Neurology, Ernst-von-Bergmann Klinikum, Potsdam, Germany.
  • Steinbrenner M; Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Angermair S; Department of Anesthesiology and Intensive Care Medicine, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Treskatsch S; Department of Anesthesiology and Intensive Care Medicine, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Zickler D; Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Germany.
  • Eckardt KU; Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Germany.
  • Dersch R; Clinic of Neurology and Neurophysiology, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
  • Hosp J; Clinic of Neurology and Neurophysiology, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
  • Audebert HJ; Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Endres M; Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany; German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany; Center for Stroke Research Berlin, Berlin, Germany; Excellence Cluster NeuroCure, Berlin, Germany; German Centre for Cardio
  • Ploner JC; Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Prüß H; Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany; German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.
Brain Behav Immun ; 93: 415-419, 2021 03.
Article em En | MEDLINE | ID: mdl-33359380
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article